Vasoplegia
21
6
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
24%
5 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (21)
Angiotensin II in Liver Transplantation
Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)
GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.
Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients
Effect Inhaled Nitric Oxide in Adult Liver Transplant
Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II
Differential Regulation of RAAS-axis in Patients Undergoing Cardiac Surgery
Characterisation of Endothelial Cells in Different Inflammatory Pathologies
Norepinephrine Weaning Guided by the Hypotension Prediction Index in Vasoplegic Shock After Cardiac Surgery
Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.
Endotoxinemia and Vasoplegia Following Cardiothoracic Surgery With Cardiopulmonary Bypass (CPB)
Reducing Acute Kidney Injury Occurence by Administering Angiotensin II
Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock
Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery
Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery
Low Dose Corticosteroid Infusion in Vasoplegia After Cardiac Surgery (CORTIVAS-CS)
Hypotension During Extracorporeal Circulatory Support Indicated for Cardiogenic Shock
Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
Evaluation of the Association Between Pre-existing Endothelial Dysfunction and the Onset of Vasoplegia During Cardiac Surgery With Cardiopulmonary Bypass
Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue